Sunday Poster Session
Category: Colon
Jessica R. Allegretti, MD, MPH
Brigham and Women's Hospital, Harvard Medical School
Boston, MA
Pooled | ||
ADS024 (n=27) | Placebo (n=9) | |
n (%) | ||
Treatment-Emergent Adverse Events | ||
Patients with ≥1 TEAE | 17 (63) | 6 (67) |
Mild | 8 (30) | 3 (33) |
Moderate | 6 (22) | 3 (33) |
Severe | 3 (11) | 0 |
Most common TEAEs (incidence ≥20% in ADS024 arm) | ||
Diarrhea | 8 (30) | 3 (33) |
Flatulence | 7 (26) | 2 (22) |
Abdominal pain | 6 (22) | 1 (11) |
Patients with ≥1 Serious TEAE | 4 (15) | 1 (11) |
C. difficile infection | 2 (7) | 0 |
Wound infection | 1 (4) | 0 |
Abdominal pain | 1 (4) | 0 |
Treatment-Related Adverse Events | ||
Patients with ≥1 TRAE | 4 (15) | 1 (11) |
Mild | 4 (15) | 1 (11) |
Moderate | 0 | 0 |
Severe | 0 | 0 |
Most common TRAEs (incidence ≥10% in ADS024 arm) | ||
Flatulence | 3 (11) | 1 (11) |
Abdominal pain | 3 (11) | 0 |
Patients with ≥1 Serious TRAE | 0 | 0 |